Thomas, McNerney & Partners

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$52.0M
total disclosed, rounds participated
Stages

Portfolio · 1

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Thomas, McNerney & Partners' most notable exit?
Thomas, McNerney & Partners notably exited Galil Medical in May 2016 through an acquisition by BTG plc for $110M.
Which sectors does Thomas, McNerney & Partners focus on for investments?
Thomas, McNerney & Partners has a focus on the Health Tech & Life Sciences sector, as evidenced by their portfolio company Galil Medical.
Can you name a key company in Thomas, McNerney & Partners' portfolio?
A key company in Thomas, McNerney & Partners' portfolio was Galil Medical, which specializes in cryotherapy for cancer treatment.
When did Thomas, McNerney & Partners make its investment in Galil Medical?
Thomas, McNerney & Partners invested in Galil Medical in December 2006.
What was the total amount raised by Galil Medical, a portfolio company of Thomas, McNerney & Partners?
Galil Medical, a portfolio company of Thomas, McNerney & Partners, raised $52M.